Background and aim: The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII). Methods and results: Questionnaires investigating the organisation of diabetes care centres, individuals’ clinical and metabolic features and pump technology and its management were sent to adult and paediatric diabetes centres that use CSII for treatment in Italy. Information on standard clinical variables, demographic data and acute and chronic diabetic complications was derived from local clinical management systems. The sample consisted of 6623 people with diabetes, which was obtained from 93 centres. Of them, 98.8% had type 1 diabetes mellitus, 57.2% were female, 64% used a conventional insulin pump and 36% used a sensor-augmented insulin pump. The median glycated haemoglobin (HbA1c) level was 60 mmol/mol (7.6%). The HbA1ctarget (i.e. <58 mmol/mol for age <18 years and <53 mmol/mol for age >18 years) was achieved in 43.4% of paediatric and 23% of adult participants. Factors such as advanced pump functions, higher rate of sensor use, pregnancy in the year before the study and longer duration of diabetes were associated with lower HbA1clevels. The most common chronic complications occurring in diabetes were retinopathy, microalbuminuria and hypertension. In the year before the study, 5% of participants reported ≥1 episode of severe hypoglycaemic (SH) episodes (SH) and 2.6% reported ≥1 episode of ketoacidosis. Conclusions: Advanced personal skills and use of sensor-based pump are associated with better metabolic control outcomes in Italian people with diabetes who were treated with CSII. The reduction in SH episodes confirms the positive effect of CSII on hypoglycaemia. Clinical trial registration number: NCT 02620917 (ClinicalTrials.gov).

The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII).

Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion / Lepore, G; Bonfanti, R; Bozzetto, L; Di Blasi, V; Girelli, A; Grassi, G; Iafusco, D; Laviola, L; Rabbone, I; Schiaffini, R; Bruttomesso, D Mammì F; Bruzzese, M; Schettino, M; Nuzzo, Mg; Di Blasi, V; Fresa, R; Lambiase, C; Iafusco, D; Zanfardino, A; Confetto, S; Bozzetto, L; Annuzzi, G; Alderisio, A; Riccardi, G; Gentile, S; Marino, G; Guarino, G; Zucchini, S; Maltoni, G; Suprani, T; Graziani, V; Nizzoli, M; Acquati, S; Cavani, R; Romano, S; Michelini, M; Manicardi, E; Bonadonna, R; Dei Cas, A; Dall'Aglio, E; Papi, M; Riboni, S; Manicardi, V; Manicardi, E; Manicardi, E; Pugni, V; Lasagni, A; Street, Me; Pagliani, U; Rossi, C; Assaloni, R; Brunato, B; Tortul, C; Zanette, G; Li Volsi, P; Zanatta, M; Tonutti, L; Agus, S; Pellegrini, Ma; Ceccano, P; Pozzilli, G; Anguissola, B; Buzzetti, R; Moretti, C C; Leto, G; Pozzilli, P; Manfrini, S; Maurizi, Ar; Leotta, S; Altomare, M; Abbruzzese, S; Carletti, S; Suraci, C; Filetti, S; Manca Bitti, Ml; Arcano, S; Cavallo, Mg; De Bernardinis, M; Pitocco, D; Caputo, S; Rizzi, A; Manto, A; Schiaffini, R; Cappa, M; Benevento, D; Frontoni, S; Malandrucco, I; Morano, S; Filardi, T; Lauro, D; Marini, Ma; Castaldo, E; Sabato, D; Tuccinardi, F; Forte, E; Viterbori, P; Arnaldi, C; Minuto, N; D'Annunzio, G; Corsi, A; Rota, R; Scaranna, C; Trevisan, R; Valentini, U; Girelli, A; Bonfadini, S; Zarra, E; Plebani, A; Prandi, E; Felappi, B; Rocca, A; Meneghini, E; Galli, P; Ruggeri, P; Carrai, E; Fugazza, L; Baggi, V; Conti, D; Bosi, E; Laurenzi, A; Caretto, A; Molinari, C; Orsi, E; Grancini, V; Resi, V; Bonfanti, R; Favalli, V; Bonura, C; Rigamonti, A; Bonomo, M; Bertuzzi, F; Pintaudi, B; Disoteo, O; Perseghin, G; Perra, S; Chiovato, L; De Cata, P; Zerbini, F; Lovati, E; Laneri, M; Guerraggio, L; Bossi, Ac; De Mori, V; Galetta, M; Meloncelli, I; Aiello, A A; Di Vincenzo, S; Nuzzi, A; Fraticelli, E; Ansaldi, E; Battezzati, M; Lombardi, M; Balbo, M; Lera, R; Secco, A; De Donno, V; Cadario, F; Savastio, S; Ponzani, C; Aimaretti, G; Rabbone, I; Ignaccolo, G; Tinti, D; Cerutti, F; Bari, F; Giorgino, F; Piccinno, E; Zecchino, O; Cignarelli, M; Lamacchia, O; Picca, G; De Cosmo, S; Rauseo, A; Tomaselli, L; Tumminia, A; Egiziano, C; Scarpitta, Am; Maggio, F; Cardella, F; Roppolo, R; Provenzano, V; Fleres, M; Scorsone, A; Scatena, A; Gregori, G; Lucchesi, S; Gadducci, F; Di Cianni, S; Pancani, S; Del Prato, S; Aragona, M; Crisci, I; Calianno, A; Fattor, B; Crazzolara, D; Reinstadler, P; Longhi, S; Incelli, G; Rauch, S; Romanelli, T; Orrasch, M; Cauvin, V; Franceschi, R; Lalli, C; Pianta, A; Marangoni, A; Aricò, Cn; Marin, N; Nogara, N; Simioni, N; Filippi, A; Gidoni Guarneri, Gl; Contin M, L ML; Decata, Ap; Bondesan, L; Confortin, L; Coracina, A; Lombardi, S; Costa Padova, S; Cipponeri, E; Scotton, R; Galasso, S; Boscari, F; Zanon, Ms; Vinci, C; Lisato, G; Gottardo, L; Bonora, E; Trombetta, M; Negri, C; Brangani, C; Maffeis, C; Sabbion, A; Marigliano, M.. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 0939-4753. - 28:4(2018), pp. 335-342. [10.1016/j.numecd.2017.12.001]

Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion

Buzzetti R;Filetti S;Cavallo MG;Morano S;Filardi T;MARIGLIANO, MANUELA;Leto G;Pozzilli P;DE BERNARDINIS, MARZIA
2018

Abstract

The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII).
Background and aim: The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII). Methods and results: Questionnaires investigating the organisation of diabetes care centres, individuals’ clinical and metabolic features and pump technology and its management were sent to adult and paediatric diabetes centres that use CSII for treatment in Italy. Information on standard clinical variables, demographic data and acute and chronic diabetic complications was derived from local clinical management systems. The sample consisted of 6623 people with diabetes, which was obtained from 93 centres. Of them, 98.8% had type 1 diabetes mellitus, 57.2% were female, 64% used a conventional insulin pump and 36% used a sensor-augmented insulin pump. The median glycated haemoglobin (HbA1c) level was 60 mmol/mol (7.6%). The HbA1ctarget (i.e. <58 mmol/mol for age <18 years and <53 mmol/mol for age >18 years) was achieved in 43.4% of paediatric and 23% of adult participants. Factors such as advanced pump functions, higher rate of sensor use, pregnancy in the year before the study and longer duration of diabetes were associated with lower HbA1clevels. The most common chronic complications occurring in diabetes were retinopathy, microalbuminuria and hypertension. In the year before the study, 5% of participants reported ≥1 episode of severe hypoglycaemic (SH) episodes (SH) and 2.6% reported ≥1 episode of ketoacidosis. Conclusions: Advanced personal skills and use of sensor-based pump are associated with better metabolic control outcomes in Italian people with diabetes who were treated with CSII. The reduction in SH episodes confirms the positive effect of CSII on hypoglycaemia. Clinical trial registration number: NCT 02620917 (ClinicalTrials.gov).
File allegati a questo prodotto
File Dimensione Formato  
Lepore_metabolic-control_2018.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 434.8 kB
Formato Adobe PDF
434.8 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1176502
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact